Home/ Supplements/ Vitamin K/ ArthroCare Advanced Extra Strength Formu...

ArthroCare Advanced Extra Strength Formula

product on market Capsule Lidtke Safety: 96/100
96/100

This product looks safe

  • Manganese: 12mg is 1.1× the Tolerable Upper Intake Level (11mg)
  • 60% of ingredients have research evidence
C Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This formula contains Vitamin D3, K, and essential minerals like zinc, copper, and manganese, which are associated with bone health and metabolic function. Research provides moderate evidence for these nutrients in supporting skeletal integrity. However, overall evidence coverage for this specific ingredient combination is limited.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Manganese: 12mg is 1.1× the Tolerable Upper Intake Level (11mg)

Label

Product Label

Label for ArthroCare Advanced Extra Strength Formula
Open Full PDF View on NIH DSLD →
Details

Label Data

4 Capsule(s)
Serving Size
22.5
Servings
Other Combinations
Product Type
60%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

500 mcg (600% DV)
4.2× RDA — above typical dose 275 studies (A:9, B:175)
1000 IU (250% DV)
1.7× RDA — within safe limits 608 studies (A:16, B:251)
5 mg (30% DV)
Within RDA (0.5× RDA) 263 studies (A:6, B:134)
1 mg (50% DV)
1.1× RDA — within safe limits 37 studies (A:0, B:11)
12 mg (600% DV)
Exceeds UL by 1.1× (UL: 11 mg) 9 studies — no high-quality reviews
Market median: 600.0mg (79 products) 25 studies (A:0, B:6)
organic Rosehips powder
500 mg
Market median: 108.0mg (8 products) 9 studies (A:0, B:4)
150 mg
Market median: 200.0mg (136 products) 3 studies — no high-quality reviews
1 mg
Market median: 3.0mg (58 products) 3 studies — no high-quality reviews

Other Ingredients

Vegetarian Capsule
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions (Adults): Take four (4) capsules twice per day or directed by your doctor.

Warnings & Precautions

Caution: Keep out of reach of children.

If you are pregnant, lactating, taking any medications, or have a medical condition, consult your doctor.

Discontinue use if adverse reaction occurs. Do not use if seal is damaged or missing.

Adverse events may be reported above.

Formulation Notes

Every day, your joints undergo normal wear and tear from daily activities or the stress caused by exercise. These daily activities can lead to joints, ligaments, or tendons that are stiff and sore. Lidtke designed ArthroCare to: Promote flexibility and movement Maintain healthy joints free of minor pain Support joint and cartilage health

ArthroCare is free of glucosamine or other simple sugars that may aggravate glucose intolerance or yeast conditions.

Superb quality since 1994 Advanced extra strength formula For healthy joints Strong ligaments & Tendons Purest on the planet

Additional Information

Thank you for choosing ArthroCare by Lidtke. We sincerely wish the best of health for you and your family.

Lidtke stands behind each product and guarantees customer satisfaction for 365 days from the date of purchase.

Keep lid tightly closed. Keep in a cool, dry place.

Metadata

Product Details

UPC / SKU6 30610 00368 1
DSLD Entry Date2021-11-19
Product TypeOther Combinations
FormCapsule
BrandLidtke
DSLD ID257176
Data Updated2026-04-11
Research

Research Evidence

332
Research Sources
59
Avg Quality
220
Meta Analysis
56
Systematic Review
30
Rct
16
Clinical Trial
3
Guideline
3
Regulatory Source
1
Narrative Review
1
Other
1
Openfda Safety
A Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Antiplatelet agents and anticoagulants for hypertension
Systematic Review The Cochrane database of systematic reviews 2022 PubMed DOI
A Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
A Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
View all evidence for Vitamin K →
Compare

Similar Products

View all Vitamin K products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.